Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response.
about
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial.Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model.
P2860
Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Concomitant combination of act ...... improves anti-tumor response.
@en
Concomitant combination of act ...... improves anti-tumor response.
@nl
type
label
Concomitant combination of act ...... improves anti-tumor response.
@en
Concomitant combination of act ...... improves anti-tumor response.
@nl
prefLabel
Concomitant combination of act ...... improves anti-tumor response.
@en
Concomitant combination of act ...... improves anti-tumor response.
@nl
P2093
P2860
P1476
Concomitant combination of act ...... improves anti-tumor response.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00262-012-1345-Y
P577
2012-09-02T00:00:00Z
P5875
P6179
1001870499